Oxford Vacmedix UK Limited
PrivateLast Round
Corporate Funding
Sep 1, 2026
Est. Valuation
$54M
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oxford Vacmedix UK Limited operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Corporate Funding round in September 2026.
Oxford Vacmedix UK Limited is a biotechnology company that develops therapeutic cancer vaccines using its proprietary Recombinant Overlapping Peptide (ROP) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Vacmedix UK Limited Comparables
Compare Oxford Vacmedix UK Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MimiVax Inc. | 80% | |
| Nykode Therapeutics | 77% | |
| Scancell Holdings Plc | 75% |
For institutional investors. Book with your work email.
Oxford Vacmedix UK Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 1, 2026 | ||||
| Series B | Nov 1, 2024 | ||||
| Grant | Jul 31, 2024 | ||||
| Grant | Dec 19, 2019 | ||||
| Grant | Jul 2, 2019 | ||||
Series A | Mar 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oxford Vacmedix UK Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Proven Connect | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
$500K raised in corporate funding.
- Jul 25, 2026
Monthly visitors increased 34% MoM, reaching 2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 4, 2026
Oxford Vacmedix UK Limited, established as an Oxford University spinout in Sep '12 and based at Oxford Science Park in United Kingdom, aims to develop therapeutic agents for the treatment of cancer.
For institutional investors. Book with your work email.
Oxford Vacmedix UK Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxford Vacmedix UK Limited's valuation, stock price, and market status.
Is Oxford Vacmedix UK Limited a public or private company?
Oxford Vacmedix UK Limited is a private company.
What is the current stock price of Oxford Vacmedix UK Limited?
Oxford Vacmedix UK Limited is a private company, so its shares have no public market price. Caplight tracks Oxford Vacmedix UK Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxford Vacmedix UK Limited worth (valuation)?
Oxford Vacmedix UK Limited's valuation is estimated at $54.0M based on funding round data.
Can I buy Oxford Vacmedix UK Limited stock?
Oxford Vacmedix UK Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxford Vacmedix UK Limited's last funding round?
Oxford Vacmedix UK Limited's most recent funding round was Corporate Funding on September 1, 2026.
Who are the main investors in Oxford Vacmedix UK Limited?
Key investors in Oxford Vacmedix UK Limited include Innovate UK, Proven Connect.
Will Oxford Vacmedix UK Limited IPO soon?
No public IPO plans have been announced for Oxford Vacmedix UK Limited.
How can I track Oxford Vacmedix UK Limited secondary market activity?
Caplight tracks bids, offers, and trades in Oxford Vacmedix UK Limited's shares on secondary markets.